This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Tim Guilliams
CEO and Co-Founder at Healx


Tim is a tech entrepreneur from the Cambridge Cluster (UK). He is passionate about the application of artificial intelligence for drug discovery. He is the co-founder and Chief Executive of Healx Ltd, a tech company focused on accelerating treatments for rare diseases. Passionate about patient impact, he is also the co-founder and a Trustee of the Cambridge Rare Disease Network. He obtained his PhD from Cambridge University in Biophysics and his MEng in Biochemical-Engineering from Brussels University.

Tim Guilliams's Network

Agenda Sessions

  • Demystifying the value of AI for rare disease science and treatment


Speakers at this event